Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14YJM | ISIN: US0130911037 | Ticker-Symbol: 27S
Tradegate
09.01.25
18:59 Uhr
19,400 Euro
+0,100
+0,52 %
Branche
Handel/E-Commerce
Aktienmarkt
Sonstige
1-Jahres-Chart
ALBERTSONS COMPANIES INC Chart 1 Jahr
5-Tage-Chart
ALBERTSONS COMPANIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
19,10019,40009.01.
19,10019,40009.01.
PR Newswire
173 Leser
Artikel bewerten:
(1)

Preferabli, the Leading AI-driven Software in Wine, Spirits and Food, Announces Partnership with Albertsons Companies

Finanznachrichten News

Partnership to Revolutionize Personalized Wine Discovery in Grocery Retail

NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Preferabli, the leading AI-driven, B2B2C product discovery and recommendation software in wine, spirits and food is excited to announce its strategic partnership with Albertsons Cos.' direct-to-consumer wine shipping platform Vine & Cellar Reserve. Available now exclusively to customers in California, shoppers can now embark on a personalized journey to discover their ideal wines from Vine & Cellar Reserve's extensive collection using Preferabli Sensorial AI?.

Preferabli, the Leading AI-driven Software in Wine, Spirits and Food, Announces Partnership with Albertsons Companies

The Science Behind the Magic
Preferabli is revolutionizing the way shoppers discover the wines they will love by offering experiences rooted in individual taste preference. The Vine & Cellar Reserve experience includes rich content, guided recommendations, and a showcase for wines with similar taste characteristics. Shoppers can also get food pairing recommendations.

This partnership marks the first time such advanced technology has been integrated into a highly curated collection on a grocery retailing platform, highlighting Albertsons Cos. and Preferabli's dedication to creating innovative, personalized experiences in grocery retail.

Pam Dillon, co-founder and CEO of Preferabli, explains, "We're imagining a world driven by individual preferences, using machine intelligence with human touch. Our software extends the bounds of what human beings can do to create true and lasting customer relationships by working at scale."

The experiences are powered by Preferabli's proprietary database, using hundreds of characteristics for each wine. Andrew Sussman, co-founder and CTO of Preferabli, adds, "Our technology gives shoppers various ways to voice what they're looking for to begin a journey of discovery. No other platform has our domain expertise or depth of quality data."

Empowering Wine Consumers
Albertsons Cos. recently launched Vine & Cellar Reserve, an expanded and enhanced version of Vine & Cellar. Available exclusively to Safeway, Albertsons, Vons and Pavilions customers in California, the platform gives consumers the ability to discover and shop a diverse selection of wines from well-known everyday favorites to specialty wines from smaller vineyards around the world, typically unavailable at national supermarket retailers. Each wine in the collection is handpicked by Master of Wine Curtis Mann and his expert buying team. Vine & Cellar Reserve offers wines ranging in price from $10 to more than $1,000 per bottle, with plans to further expand the assortment.

"Vine & Cellar Reserve was created to give customers access to a curated selection of premier wines from around the world," said Curtis Mann, Group Vice President of Alcohol for Albertsons Cos. and Master of Wine. "By partnering with Preferabli, we're helping customers receive personalized recommendations based on their individual preferences, learn about the wines they are considering and ultimately, find and discover new wines."

Why it's Different
Using a novel form of machine learning protected by 12 patents, Preferabli was built by PhDs in physiology and applied mathematics, and the largest group of Masters of Wine and Master Sommeliers in the world. All functionalities use its proprietary database, the most comprehensive in the industry with hundreds of characteristics for millions of products. Preferabli connects people to products on a 1:1 basis -- making taste-based recommendations based on individual preferences, not crowdsourcing. Preferabli is as intuitive as a human expert, at scale.

To visit Vine & Cellar Reserve, https://www.vinecellarreserve.com/.

About Preferabli?
Preferabli is the leading AI-driven B2B2C product discovery and recommendation software for wine, spirits and food -- trusted by specialty and grocery retail, hospitality, travel, distribution and consumer platforms. Preferabli solutions cover wine, spirits, beer, ready-to-drink beverages and food, including cheese. Preferabli has users in over 70 countries. Preferabli for consumers is available on iOS and Android. For more information, please visit https://preferabli.com.

Powered by Preferabli

Vine & Cellar Reserve

Photo - https://mma.prnewswire.com/media/2577610/Preferabli_Partnership_with_Albertsons_Companies.jpg
Logo - https://mma.prnewswire.com/media/2575917/Powered_by_Preferabli_Logo.jpg
Logo - https://mma.prnewswire.com/media/2575919/Vine_Cellar_Reserve_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/preferabli-the-leading-ai-driven-software-in-wine-spirits-and-food-announces-partnership-with-albertsons-companies-302327294.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.